BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8698355)

  • 1. Combined therapy trial with interferon alpha-2a and ablative therapy in the treatment of anogenital warts.
    Armstrong DK; Maw RD; Dinsmore WW; Blaakaer J; Correa MA; Falk L; Ferenczy AS; Fortier M; Frazer I; Law C; Moller BM; Oyakawa N
    Genitourin Med; 1996 Apr; 72(2):103-7. PubMed ID: 8698355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous interferon alpha 2a combined with cryotherapy vs cryotherapy alone in the treatment of primary anogenital warts: a randomised observer blind placebo controlled study.
    Handley JM; Horner T; Maw RD; Lawther H; Dinsmore WW
    Genitourin Med; 1991 Aug; 67(4):297-302. PubMed ID: 1916791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised, double-blind, parallel group study to compare subcutaneous interferon alpha-2a plus podophyllin with placebo plus podophyllin in the treatment of primary condylomata acuminata.
    Armstrong DK; Maw RD; Dinsmore WW; Morrison GD; Pattman RS; Watson PG; Nathan PM; Moss T; Nayagam A; Wade A
    Genitourin Med; 1994 Dec; 70(6):389-93. PubMed ID: 7705855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent condylomata acuminata treated with recombinant interferon alpha-2a. A multicenter double-blind placebo-controlled clinical trial. Condylomata International Collaborative Study Group.
    Acta Derm Venereol; 1993 Jun; 73(3):223-6. PubMed ID: 8105627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A placebo controlled observer blind immunocytochemical and histologic study of epithelium adjacent to anogenital warts in patients treated with systemic interferon alpha in combination with cryotherapy or cryotherapy alone.
    Handley JM; Maw RD; Horner T; Lawther H; Walsh M; Dinsmore WW
    Genitourin Med; 1992 Apr; 68(2):100-5. PubMed ID: 1316307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of condylomata acuminata following cryotherapy is not prevented by systemically administered interferon.
    Eron LJ; Alder MB; O'Rourke JM; Rittweger K; DePamphilis J; Pizzuti DJ
    Genitourin Med; 1993 Apr; 69(2):91-3. PubMed ID: 8509099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent condylomata acuminata treated with recombinant interferon alfa-2a. A multicenter double-blind placebo-controlled clinical trial. Condylomata International Collaborative Study Group.
    JAMA; 1991 May 22-29; 265(20):2684-7. PubMed ID: 2023348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized placebo-controlled double-blind combined therapy with laser surgery and systemic interferon-alpha 2a in the treatment of anogenital condylomata acuminatum. The Condylomata International Collaborative Study Group.
    J Infect Dis; 1993 Apr; 167(4):824-9. PubMed ID: 8450247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-specific immunity in patients with primary anogenital warts treated with interferon alpha plus cryotherapy or cryotherapy alone.
    Handley JM; Maw RD; Horner T; Lawther H; McNeill T; Dinsmore WW
    Acta Derm Venereol; 1992; 72(1):39-40. PubMed ID: 1350140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemically administered interferon alfa-2a prevents recurrence of condylomata acuminata following CO2-laser ablation. The influence of the cyclic low-dose therapy regimen. Results of a multicentre double-blind placebo-controlled clinical trial.
    Gross G; Roussaki A; Baur S; Wiegand M; Mescheder A
    Genitourin Med; 1996 Feb; 72(1):71. PubMed ID: 8655177
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized trial of combination therapy with intralesional interferon alpha 2b and podophyllin versus podophyllin alone for the therapy of anogenital warts.
    Douglas JM; Eron LJ; Judson FN; Rogers M; Alder MB; Taylor E; Tanner D; Peets E
    J Infect Dis; 1990 Jul; 162(1):52-9. PubMed ID: 2192011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic interferon alpha-2b increases the cure rate in laser treated patients with multiple persistent genital warts: a placebo-controlled study.
    Petersen CS; Bjerring P; Larsen J; Blaakaer J; Hagdrup H; From E; Obergaard L
    Genitourin Med; 1991 Apr; 67(2):99-102. PubMed ID: 2032716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of genital HPV infection with carbon dioxide laser and systemic interferon alpha-2b.
    Nieminen P; Aho M; Lehtinen M; Vesterinen E; Vaheri A; Paavonen J
    Sex Transm Dis; 1994; 21(2):65-9. PubMed ID: 9071414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intralesional interferon alfa-2b for the treatment of genital warts.
    Welander CE; Homesley HD; Smiles KA; Peets EA
    Am J Obstet Gynecol; 1990 Feb; 162(2):348-54. PubMed ID: 2155531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre, randomised, double-blind, placebo controlled study of cryotherapy versus cryotherapy and podophyllotoxin cream as treatment for external anogenital warts.
    Gilson RJ; Ross J; Maw R; Rowen D; Sonnex C; Lacey CJ
    Sex Transm Infect; 2009 Dec; 85(7):514-9. PubMed ID: 19700413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled trial of systemically administered interferon-alpha, -beta, or -gamma in combination with cryotherapy for the treatment of condyloma acuminatum.
    Bonnez W; Oakes D; Bailey-Farchione A; Choi A; Hallahan D; Pappas P; Holloway M; Corey L; Barnum G; Dunne A
    J Infect Dis; 1995 May; 171(5):1081-9. PubMed ID: 7538546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous interferon alpha in the treatment of refractory condylomata.
    Paavonen J
    Sex Transm Dis; 1990; 17(3):152-3. PubMed ID: 2247806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte derived interferon-alpha in a hydrophilic gel for the treatment of intravaginal warts in women: a placebo-controlled, double-blind study.
    Syed TA; Ahmadpour OA
    Int J STD AIDS; 1998 Dec; 9(12):769-72. PubMed ID: 9874127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anogenital warts: a new way of solving the common problem of urology (results of long-term follow-up)].
    Protasov AD; Lipatov IS; Kostinov MP; Tezikov YV; Shmitko AD; Pakhomov DV; Blagovidov DA; Zhestkov AV; Ryzhov AA; Vekhova EV
    Urologiia; 2016 Nov; (5):47-51. PubMed ID: 28248020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of 0.5% podofilox solution in the treatment and suppression of anogenital warts.
    Bonnez W; Elswick RK; Bailey-Farchione A; Hallahan D; Bell R; Isenberg R; Stoler MH; Reichman RC
    Am J Med; 1994 May; 96(5):420-5. PubMed ID: 8192173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.